Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)

ClinicalTrials.gov ID: NCT01343966

Public ClinicalTrials.gov record NCT01343966. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 6:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter, Phase II Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase II, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the safety and efficacy of MABT5102A in patients with mild to moderate Alzheimer's Disease.

Study identification

NCT ID
NCT01343966
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
448 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2011 (Actual)
Primary completion
Feb 28, 2014 (Actual)
Completion
Feb 28, 2014 (Actual)
Last update posted
Jul 12, 2017

2011 – 2014

United States locations

U.S. sites
40
U.S. states
17
U.S. cities
39
Facility City State ZIP Site status
Hope Research Institute Phoenix Arizona 85050 —
Mayo Clinic Scottsdale Arizona 85259 —
Pharmacology Research Inst Encino California 91316 —
Margolin Brain Institute Fresno California 93720 —
Univ of CA San Diego; Neurosciences Comp.Alzheimer's La Jolla California 92037 —
USC School of Medicine Los Angeles California 90033 —
Pharmacology Research Inst Newport Beach California 92660 —
University of California Davis Medical System Sacramento California 95817 —
Pacific Research Network - PRN San Diego California 92103 —
Uni of California San Francisco San Francisco California 94117 —
Neurological Research Inst Santa Monica California 90025 —
Yale University New Haven Connecticut 06511 —
Florida Atlantic University; College of Medicine Boca Raton Florida 33431 —
Meridien Research Brooksville Florida 34601 —
Brain Matters Research, Inc. Delray Beach Florida 33445 —
Miami Jewish Health Systems; Clinical Research Miami Florida 33137 —
Collier Neurologic Specialists Naples Florida 34102 —
Compass Research Orlando Florida 32806 —
Axiom Clinical Research of Florida Tampa Florida 33609 —
Premiere Research Institute West Palm Beach Florida 33407 —
Rush Alzheimer's Disease Cntr. Chicago Illinois 60612 —
Alexian Brothers Neurosci Inst Elk Grove Village Illinois 60007 —
IU Healthy Partners Adult Neurology Clinic Indianapolis Indiana 46202 —
Louisiana Research Associates New Orleans Louisiana 70114 —
Millennium Psychiatric Associates, LLC Creve Coeur Missouri 63141 —
NeuroCognitive Institute Mount Arlington New Jersey 07856 —
Memory Enhancement Center of NJ, Inc. Toms River New Jersey 08755 —
Albany Medical College Albany New York 12208 —
Empire Neurology, PC Latham New York 12210 —
Columbia University Medical Center New York New York 10032 —
University of Rochester Medical Center; Monroe Community Hospital Rochester New York 14627 —
Investigational Drug Service; Univ of Rochester Medical Ctr Rochester New York 14642 —
Raleigh Neurology Associates Raleigh North Carolina 27607-6520 —
Neurology & Neuroscience Ctr of Ohio Toledo Ohio 43623 —
Clinical Trials of America, Inc. Eugene Oregon 97401 —
Summit Research Network Inc. Portland Oregon 97210 —
The Clinical Trial Center, LLC Jenkintown Pennsylvania 19046 —
Medical Uni of South Carolina North Charleston South Carolina 29425 —
Alzheimers Disease & Memory Disorders Center; Department of Neurology Baylor College of Medicine Houston Texas 77030 —
Clinical Neuroscience Research Associates, Inc. Bennington Vermont 05201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01343966, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2017 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01343966 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →